CClinicalTrials.gg
CompletedNCT04725825Updated Feb 9, 2022

Central Pain Modulatory Effects of Dry-Needling in Patients With Non-Specific Neck Pain

An interventional study of Dry needling and Sham needling in Neck Pain, Posterior and Trapezius Muscle Strain, sponsored by University Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-02-09.

Sponsored by University Ghent · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

An experimental study will be conducted to evaluate the effect of a single dry needling session, compared to a sham needling session, on pain intensity, local and peripheral hyperalgesia, and conditioned pain modulation in patients with chronic idiopathic neck pain.

Read the detailed description

Chronic idiopathic neck pain frequently has a myofascial origin. This cervical myofascial pain is caused by myofascial trigger points (MTrPs). Myofascial trigger points are defined as hyperirritable nodules in a contracture of skeletal muscle fibers, which can cause pain symptoms, motor symptoms as well as autonomic symptoms.

Many chronic pain populations (e.g. chronic whiplash associated disorders, fibromyalgia, chronic low back pain) show impaired pain processing and signs of central sensitisation. Central pain processing is defined as an increased responsivity of the nociceptive neurons in the central nerve system and is characterized by hyperalgesia (increased pain after a painful stimuli), allodynia (pain caused by a non-painful stimuli) and temporal summation (increased pain response after repeated stimuli with the same intensity). Hyperalgesia can be divided in local (increased sensitivity in the area of the complaints) and peripheral (increased sensitivity at remote area's). Furthermore, deficient inhibitory pain modulation can be present in this population. Conditioned pain modulation (CPM) can be measured by combining a painful conditioning stimuli (e.g. cold or heat) on a remote location, with a painful test stimuli.

Cervical myofascial pain is often treated by dry needling (DN). DN is a myofascial treatment technique, which has been gaining interest in recent years. During DN, a thin, solid filiform needle is inserted directly into the MTrP. During this treatment, local twitch responses can be elicited. These are involuntary contractions of muscle fibers, leading to muscle relaxation, an increased local blood flow, recovery of the muscle metabolism and thus a reduction of pain and stiffness. By deactivation of the source of pain, chronification of the pain can be prevented.

Up to this moment, there are no studies that investigated the central effects of DN. The aim of this study is to compare the effects of DN with sham needling on pain intensity, local and peripheral hyperalgesia and CPM, in patients with chronic idiopathic neck pain. Therefore, 100 patients will be recruited. Participants are included based on online questionnaires, a clinical examination of neck and shoulder, and the identification of a MTrP in the upper trapezius muscle. All participants will receive information and have to sign an informed consent form. Participants will be subjected to baseline assessment, which involves measurements of pain scores, hyperalgesia (pressure pain thresholds (PPT) by algometry) and CPM (by combining immersion of the hand in hot water while repeating the PPT). Then, participants will be randomly allocated to either a dry needling group or a sham needling group. The dry needling group will receive a dry needling treatment at the identified trigger point location of the upper trapezius, whereas the sham needling group will receive an intervention in which the needle only penetrates the skin but not the fascia and muscle tissue. The one-time intervention of both groups will take approximately 15 minutes. After the treatment, the baseline measurements will be repeated.

02

Conditions studied

  • Neck Pain, Posterior
  • Trapezius Muscle Strain

Browse trials for

Keywords

  • Dry Needling
  • Sham Needling
  • Myofascial Pain Syndrome
  • Central Pain Modulatory Effects
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's enrollment of 54 is close to the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chronic neck pain (symptom duration >3 months)
  • Mean NRS score >3/10
  • The presentation of a clinically relevant myofascial triggerpoint in the upper trapezius muscle.

Exclusion criteria

Exclusion Criteria:

  • Specific neck pain (eg.structural pathology like a cervical discus hernia, cervical nerve root compression, factures...)
  • Major depression or psychiatric illness
  • Cardiovascular, neurological, life threatening, systemic and metabolic diseases
  • Other transferable diseases (HIV, hepatitis...)
  • Coagulation disorders or use of coagulation medication
  • Pregnancy or given birth the last year
  • Traumatic injuries/surgery to neck and upper limb region
  • Diagnosis of fibromyalgia/chronic fatigue syndrome
  • BMI > 30 kg/m2.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Dry needling

    A single dry needling session will be performed on the dominant painful trapezius muscle, with the patient lying in prone position. After palpation of a taut band, and detection of a MTrP in the upper trapezius muscle, a trained physiotherapist will penetrate the needle into skin surface, fascia, into the muscle tissue at the MTrP location, and will move the needle up and down (fast-in, fast-out technique) in three different directions. In case local twitch responses are elicited, this will be repeated until the local twitch responses are extinct.

    Other: Dry needling

  • Sham comparator
    Sham needling

    A single sham needling session will be performed with the subject lying on the non painful side. After palpation of a taut band, and detection of a MTrP in the upper trapezius muscle, a trained physiotherapist will penetrate the needle into the skin surface at the MTrP location. The fascia and muscle tissue will not be penetrated.

    Other: Sham needling

Interventions

  • OtherDry needling

    Dry needling (DN) is a myofascial treatment technique, in which a thin, solid filiform needle is inserted directly into the MTrP. During dry needling, local twitch responses (LTR) can be elicited. These are involuntary contractions of muscle fibers, leading to muscle relaxation, an increase in blood flow,recovery of the muscle metabolism and thus a reduction of pain and stiffness.

  • OtherSham needling

    During sham needling, a solid, filiform needle is inserted in the skin surface at the trigger point location, without penetrating the fascia and muscle tissue.

06

What researchers measure

Primary outcomes

  1. Change in distant Pressure Pain Threshold

    A distant standardised PPT will be assessed using a digital handheld pressure algometer (FDX; Wagner Instruments) at the quadriceps muscle of the dominant painful side to measure distant hyperalgesia. To measure the PPT, the researcher will apply the digital algometer to each of the indicated points with a round rubber end of 1 cm² and an increasing pressure of circa 1 N/s. As soon as the sensation of the subject shifts from a comfortable pressure to an altered, unpleasant feeling, the participant reports this and the test will be finished. Each point will be measured twice with a 30-second interval in between and all measurements will be performed by one researcher in the same standardised position for each point and will be executed in a randomised order per patient.

    Time frame: Baseline and immediately after the intervention

Secondary outcomes

  1. Numeric Rating Scale (NRS)

    The neck pain of the patients will be rated on an 11-point NRS at the beginning of the trial. After the hot water immersion (CPM; at baseline and post-intervention), patients will also be asked to score the pain caused by the hot water on a NRS. Minimum value is zero; a score of zero means no pain (= better outcome) and maximum score is 10, which indicates the worst pain possible (=worse outcome).

    Time frame: Baseline and immediately after the intervention

  2. Change in Conditioned Pain Modulation

    Participants will be asked to put their (non-dominant) hand (up to a marked line on the wrist) in a bath (VersaCool, Thermo Fisher Scientific, Waltham, Massachusetts) with demineralised circulating water maintained at 46,5°C for one minute. To maximise the CPM effect, the non-dominant hand will be used. During this minute, participants will be encouraged to persevere after 30 and after 45 seconds by one of the investigators. The PPTs will be used as the test stimulus.These will be measured pre- and post immersion.The difference between the pre- and post immersion PPTs will be used to assess the effectiveness of the CPM.

    Time frame: baseline and immediately after the intervention

  3. Change in local Pressure Pain Threshold

    Two local standardised PPTs will be assessed using a digital handheld pressure algometer (FDX; Wagner Instruments) at the dominant painful and non-dominant painful upper trapezius muscle to measure local hyperalgesia. To measure the PPT, the researcher will apply the digital algometer to each of the indicated points with a round rubber end of 1 cm² and an increasing pressure of circa 1 N/s. As soon as the sensation of the subject shifts from a comfortable pressure to an altered, unpleasant feeling, the participant reports this and the test will be finished. Each point will be measured twice with a 30-second interval in between and all measurements will be performed by one researcher in the same standardised position for each point and will be executed in a randomised order per patient.

    Time frame: Baseline and immediately after the intervention

07

Study locations

1 site
  • Ghent University
    Ghent, Oost-Vlaanderen 9000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04725825
Lead sponsor
University Ghent
Responsible party
VakgroepRevalidatiewetenschappen (Principal Investigator, University Ghent) — Principal investigator
First posted
Jan 27, 2021
Start date
Feb 1, 2021
Primary completion
Jul 15, 2021
Completion
Jul 15, 2021
Last update
Feb 9, 2022

Study contacts

Mira Meeus
principal investigator · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion